ABSTRACT
Testing for respiratory viruses has changed greatly over the past decade, owing to advances in technology, drug development, vaccine research, and a growing recognition of the importance of improving patient access. Here, we focus on the most common respiratory viruses and review preanalytic variables (eg, collection and storage) that affect test results, testing methods including nucleic acid amplification testing (NAAT), and controversies, challenges, and trends in diagnostic testing relevant to clinicians.
- Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.
Clicking the link below will connect you to begin the credit-claiming process for CME . After clicking on the link, scroll to the bottom of the page and click on “Complete the CME Process.” You will need your myCME login information to access this.
- Christopher C. Attaway, MD, MSc
- Hannah Wang, MD, D(ABMM)⇑
- Medical Director, Molecular Microbiology and Virology Laboratories, Robert J. Tomsich Department of Pathology and Laboratory Medicine, Diagnostics Institute, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- Correspondence:
Hannah Wang, MD, D(ABMM), Medical Director, Molecular Microbiology and Virology, Department of Laboratory Medicine, LL1-2, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; wangh7{at}ccf.org
ABSTRACT
Testing for respiratory viruses has changed greatly over the past decade, owing to advances in technology, drug development, vaccine research, and a growing recognition of the importance of improving patient access. Here, we focus on the most common respiratory viruses and review preanalytic variables (eg, collection and storage) that affect test results, testing methods including nucleic acid amplification testing (NAAT), and controversies, challenges, and trends in diagnostic testing relevant to clinicians.
- Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.